文献速递乳腺乳腺X线USMR

中等乳腺癌风险且乳腺致密女性的对比增强能谱乳腺摄影

Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
PubMed 文献 · AJR Am J Roentgenol · 2018-09-21

回顾性队列纳入2012至2017年接受筛查性对比增强能谱乳腺摄影(CESM)的611例中等风险致密乳腺女性,比较CESM、超声与标准数字乳腺摄影的诊断效能。CESM敏感度90.5%显著高于乳腺摄影的52.4%(p=0.008),特异度76.1%低于乳腺摄影的90.5%(p<0.001)。CESM增量癌症检出率为13.1/1000女性(95%CI 6.1-20.1)。

要点

  • CESM敏感度90.5%(19/21)显著高于数字乳腺摄影52.4%(11/21),特异度76.1%低于乳腺摄影90.5%。
  • 仅CESM发现的8例癌症中7例为浸润性,平均大小9mm,4例中2例淋巴结阳性。
  • CESM筛查阴性者加做超声的73个可疑发现均为假阳性,未见额外获益。

核心结论

  • 在该筛查人群中,CESM检测乳腺癌的敏感度显著高于标准数字乳腺摄影;CESM筛查阴性者加做超声未见额外获益;CESM可能作为中等风险致密乳腺女性的补充筛查方式。

研究设计与样本

  • 回顾性队列研究,纳入2012至2017年连续登记的611例接受筛查性CESM的女性,以组织病理学分析或影像随访评估实际疾病状态,计算敏感度、特异度、阳性预测值和阴性预测值。

诊断标准与关键数值

  • 乳腺摄影检出21例恶性肿瘤中的11例,敏感度52.4%,特异度90.5%(534/590),阳性预测值16.4%(11/67),阴性预测值98.2%(534/544);CESM检出21例中的19例,敏感度90.5%,特异度76.1%(449/590),阳性预测值11.9%(19/160),阴性预测值99.6%(449/451);敏感度差异p=0.008,特异度差异p<0.001;CESM增量癌症检出率13.1/1000女性(95%CI 6.1-20.1)。

临床应用与阅片要点

  • 筛查人群中48.3%(295/611)有乳腺癌家族史或个人史,BI-RADS乳腺密度评分C或D者占93.1%(569/611),平均随访20个月;39例女性需MRI评估筛查异常,行2次MRI引导活检,检出1例癌症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to compare the diagnostic performance of contrast-enhanced spectral mammography (CESM) and ultrasound with that of standard digital mammography for breast cancer screening of women at intermediate risk who have dense breasts.

MATERIALS AND METHODS: In a retrospective cohort of 611 consecutively registered women who underwent screening CESM from 2012 to 2017, BI-RADS scores of the screening modalities were compared with actual disease status, assessed by histopathologic analysis or imaging follow-up. Sensitivity, specificity, and positive and negative predictive values were calculated.

RESULTS: Among the 611 women included, 48.3% (295/611) had family or personal history of breast cancer, the BI-RADS breast density score was C or D in 93.1% (569/611). The mean follow-up period was 20 months. Mammography depicted 11 of 21 malignancies, sensitivity of 52.4%, specificity of 90.5% (534/590), positive predictive value of 16.4% (11/67), and negative predictive value of 98.2% (534/544). CESM depicted 19 of 21 malignancies, sensitivity of 90.5%, specificity of 76.1% (449/590), positive predictive value of 11.9% (19/160), and negative predictive value of 99.6% (449/451). Differences in sensitivity (p = 0.008) and specificity (p < 0.001) were statistically significant. Adjunct ultrasound revealed 73 additional suspicious findings; all were false-positive. In 39 women MRI was needed to assess screening abnormalities; two MRI-guided biopsies were performed and yielded one cancer. The incremental cancer detection rate of CESM was 13.1/1000 women (95% CI, 6.1-20.1). Of eight cancers seen only with CESM, seven were invasive (mean size, 9 mm; two of four cancers lymph-node positive).

CONCLUSION: CESM was significantly more sensitive than standard digital mammography for detecting breast cancer in this screening population. No added benefit was found in the performance of ultrasound as an adjunct to CESM screens with negative results. CESM may be a valuable supplemental screening modality for women at intermediate risk who have dense breasts.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Sorin V, Yagil Y, Yosepovich A, et al. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts. AJR Am J Roentgenol. 2018. PMID: 30240292. doi:10.2214/AJR.17.19355

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。